Lorcaserin Extended-Release Tablets and Pentamycetin Ophthalmic Solution 0.25%
Determining the interaction of Lorcaserin Extended-Release Tablets and Pentamycetin Ophthalmic Solution 0.25% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: chloramphenicol ophthalmic
Brand name:
Synonyms: Chloramphenicol (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pentamycetin Ophthalmic Solution 0.5%
- Lorcaserin Extended-Release Tablets-Pentasa
- Lorcaserin Extended-Release Tablets-Pentasa Rectal
- Lorcaserin Extended-Release Tablets-Pentazocine
- Lorcaserin Extended-Release Tablets-Pentazocine Acetaminophen
- Lorcaserin Extended-Release Tablets-Pentazocine and Naloxone
- Pentamycetin Ophthalmic Solution 0.25%-Lorcaserin Hydrochloride
- Pentamycetin Ophthalmic Solution 0.25%-Lorcaserin Tablets
- Pentamycetin Ophthalmic Solution 0.25%-Lorcet
- Pentamycetin Ophthalmic Solution 0.25%-Lorcet Plus
- Pentamycetin Ophthalmic Solution 0.25%-Lorcet Tablets
- Pentamycetin Ophthalmic Solution 0.25%-Lorlatinib